** Abbott India ABOT.NS jumps 3.5% post Q4 results
** Drugmaker's profit rises 28% y/y in Q4; rev from ops up 11%
** Co's earnings boosted by strong demand for gastrointestinal and anti-infective drugs
** Stock is top gainer in nifty pharma index .NIPHARM, which is down 0.4%
** YTD shares up 2%, set to extend gains for a second straight session
** Broader market nifty 50 index .NSEI down 0.2% on Friday
(Reporting by Yagnoseni Das in Bengaluru)
((Yagnoseni.Das@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。